1. Helsinki Heart Study Ethical Committee:Safety as a factor in lipid-regulating primary prevention drug trial: the Helsinki Heart Study Interim Report, in C. Wood (Ed.),Further progress with gemfibrozil. Royal Society Medical Services International Congress and Symposium Series, p. 87 (1986).
2. G. F. Blane:Am. J. Med. 83, 26 (1987).
3. H. U. Kloer:Am. J. Med. 83, 3 (1987).
4. K. Bork:Cutaneous Side Effects of Drugs, W. B. Saunders Company, Philadelphia, p. 252 (1988).
5. Y. Murata, M. Tani, and M. Amano:J. Am. Acad. Dermatol. 18, 381 (1988).